This web site uses cookies. Do you accept the use of external cookies? Yes No Know more x
Survey about achondroplasia
We have designed a questionnaire with the purpose to better know the population connected to achondroplasia.
The questionnaire is optional and anonymous. The data obtained will be used for statistical purposes and to better understand the natural history of achondroplasia. Please consider answering.
If you would like to take the survey later, you can click on the link at the top "Register at BA"

ASBMR 2022

The ASBMR Annual Meeting is the world’s largest and most diverse meeting in the bone, mineral and musculoskeletal research field, attracting more than 2,000 attendees from more than 60 countries, including clinicians and researchers, representing all career levels and specializing in a variety of disciplines.

Austin Convention Center 
500 E Cesar Chavez St, Austin, TX, USA
September 9-12.

Held one day prior to the Meeting, with the theme "From Molecules and Mechanisms to Therapeutics", the Symposium will gather experts in rare bone diseases. Inês Alves, founder of Beyond Achondroplasia and President of ANDO Portugal will be speaking on the subject of "The Patient’s Perspective: Patient involvement and role of patient organizations in research and clinical trials in rare bone diseases". Find the Symposium program here.

The ASBMR Discovery Hall will feature 1,100 poster presentations; Inês Alves will also be presenting a scientific poster on the first day (September 9).


With more than 100 education sessions and 1,000 poster presentations in four days. Upon returning home from the meeting, attendees will be able to discuss with confidence the most current and significant advances in biomedical and clinical research, and develop and apply new and enhanced strategies for treatment and care of patients.

For more information, visit the Meeting website here and find the full scientific program here.
To view this site you need Internet Explorer 8 (or a higher version)
or another internet browser.

Thank You.